Home Health Bristol Myers CEO says India to have largest R&D presence exterior US by 2025 – ET HealthWorld | Pharma

Bristol Myers CEO says India to have largest R&D presence exterior US by 2025 – ET HealthWorld | Pharma

0
Bristol Myers CEO says India to have largest R&D presence exterior US by 2025 – ET HealthWorld | Pharma

[ad_1]

Hyderabad: Bristol Myers Squibb goals to broaden its research and development presence in India and expects its newly inaugurated Hyderabad facility to turn into its largest unit exterior the U.S. by 2025, CEO Christopher Boerner mentioned on Tuesday.

The $100-million facility, inaugurated by Boerner on Monday, is anticipated to make use of over 1,500 staff and will probably be used to reinforce its drug growth by using digital applied sciences and synthetic intelligence, he mentioned in his keynote speech on the BioAsia convention.

Bristol Myers additionally operates a analysis and growth centre in Bengaluru in partnership with the Biocon Group‘s Syngene International.

The cancer-focused U.S. drugmaker is at present creating next-generation cell therapies for autoimmune illnesses equivalent to a number of sclerosis and plans to make use of AI applied sciences to speed up the event, Boerner mentioned.

The corporate plans to make these extra extensively out there, together with in markets equivalent to India, he added.

Bristol Myers is but to launch its most cancers cell therapies Abecma and Breyanzi within the nation, however its different most cancers medication equivalent to nivolumab and ipilimumab are offered underneath the model names Opdyta and Yervoi.

A spokesperson for the corporate didn’t instantly reply to Reuters request for touch upon availability of Abecma and Breyanzi in India.

The corporate expects its top-selling medication equivalent to blood thinner Eliquis and most cancers immunotherapy Opdivo to lose patent safety in key markets later this decade and introduced a string of offers late final yr to restock its drug growth pipeline.

  • Printed On Feb 27, 2024 at 04:23 PM IST

Be part of the group of 2M+ business professionals

Subscribe to our publication to get newest insights & evaluation.

Obtain ETHealthworld App

  • Get Realtime updates
  • Save your favorite articles


Scan to obtain App


[ad_2]

Source link

LEAVE A REPLY

Please enter your comment!
Please enter your name here